Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infection

Journal of Interferon and Cytokine Research

Volumn 30, Issue 4, 2010, Pages 263-272

  Corn Minor, Radiah A ^a   Limmon, Gino V ^b   Miller Degraff, Laura ^c   Dixon, Darlene ^c   Andrews, Danica M K ^c   Kaufman, Randal J ^d   Imani, Farhad ^c  

^a NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^b SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN ADAR; PROTEIN KINASE; PROTEIN KINASE R; RANTES; RNA HELICASE; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; EOSINOPHIL; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOREGULATION; INNATE IMMUNITY; LUNG; LUNG INFILTRATE; LUNG INJURY; LUNG LAVAGE; LYMPHOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; WILD TYPE;

ANIMALS; CHEMOKINES; EIF-2 KINASE; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; IMMUNITY, INNATE; LUNG; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; VIRAL LOAD; VIRUS REPLICATION;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 77952500770     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0051     Document Type: Article

References (64)

1. Arnold R, Humbert B, Werchau H, Gallati H, Konig W. 1994. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82 (1):126-133.
2. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, Archer DR, Barber GN. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 (1):129-141.
3. Baltzis D, Li S, Koromilas AE. 2002. Functional characterization of pkr gene products expressed in cells from mice with a targeted deletion of the N terminus or C terminus domain of PKR. J Biol Chem 277 (41):38364-38372.
4. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97 (22):12289-12294.
5. Boothby MR, Mora AL, Scherer DC, Brockman JA, Ballard DW. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF) - kappaB. J Exp Med 185 (11):1897-1907.
6. Carr DJ, Wuest T, Tomanek L, Silverman RH, Williams BR. 2006. The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection. Immunology 118 (4):520-526.
7. de Haro C, Mendez R, Santoyo J. 1996. The eIF-2alpha kinases and the control of protein synthesis. FASEB J 10 (12):1378-1387.
8. Delphin S, Stavnezer J. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50. J Exp Med 181 (1):181-192.
9. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. 2002. The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 168 (6):2944-2952.
10. Estripeaut D, Torres J P, Somers CS, Tagliabue C, Khokhar S, Bhoj VG, Grube SM, Wozniakowski A, Gomez AM, Ramilo O, Jafri HS, Mejias A. 2008. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model. J Infect Dis 198 (10):1435-1443.
11. Franke G, Freihorst J, Steinmuller C, Verhagen W, Hockertz S, Lohmann-Matthes ML. 1994. Interaction of alveolar macrophages and respiratory syncytial virus. J Immunol Methods 174 (1-2): 173-184.
12. Galabru J, Katze MG, Robert N, Hovanessian AG. 1989. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur J Biochem 178 (3):581-589. (Pubitemid 19026211)
13. García MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, Esteban M. 2006. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70 (4):1032-1060.
14. Gern JE, French DA, Grindle KA, Brockman-Schneider RA, Konno S, Busse WW. 2003. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am J Respir Cell Mol Biol 28 (6):731-737.
15. Gil J, Rullas J, Garcia MA, Alcami J, Esteban M. 2001. The catalytic activity of dsRNA-dependent protein kinase, PKR, is required for NF-kappaB activation. Oncogene 20 (3):385-394.
16. Goh KC, deVeer MJ, Williams BR. 2000. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 19 (16):4292-4297.
17. Graham BS, Johnson TR, Peebles RS. 2000. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 48 (3):237-247.
18. Graham BS, Perkins MD, Wright PF, Karzon DT. 1988. Primary respiratory syncytial virus infection in mice. J Med Virol 26 (2):153-162.
19. Guidotti LG, Morris A, Mendez H, Koch R, Silverman RH, Williams BR, Chisari F V. 2002. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice. J Virol 76 (6):2617-2621.
20. Hall CB, Douglas RG, Jr., Geiman JM. 1976. Respiratory syncytial virus infections in infants: quantitation and duration of shedding. J Pediatr 89 (1):11-15.
21. Hussell T, Pennycook A, Openshaw PJ. 2001. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 31 (9):2566-2573.
22. Jacobs BL, Langland JO. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219 (2):339-349.
23. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O. 2004. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 189 (10):1856-1865.
24. Jaradat M, Stapleton C, Tilley SL, Dixon D, Erikson CJ, McCaskill JG, Kang HS, Angers M, Liao G, Collins J, Grissom S, Jetten AM. 2006. Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation. Am J Respir Crit Care Med 174 (12):1299-1309.
25. Kehoe KE, Brown MA, Imani F. 2001. Double-stranded RNA regulates IL-4 expression. J Immunol 167 (5):2496-2501.
26. Kong X, San Juan H, Behera A, Peeples ME, Wu J, Lockey RF, Mohapatra SS. 2004. ERK-1/2 activity is required for efficient RSV infection. FEBS Lett 559 (1-3): 33-38.
27. Krust B, Galabru J, Hovanessian AG. 1984. Further characterization of the protein kinase activity mediated by interferon in mouse and human cells. J Biol Chem 259 (13):8494-8498.
28. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80 (5):707-718.
29. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR. 1994. Doublestranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA 91 (14):6288-6292.
30. Langland JO, Kao PN, Jacobs BL. 1999. Nuclear factor-90 of activated T-cells: A double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry 38 (19):6361-6368.
31. Lebleu B, Sen GC, Shaila S, Cabrer B, Lengyel P. 1976. Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci USA 73 (9):3107-3111.
32. Leibovitz E, Freihorst J, Piedra PA, Ogra PL. 1988. Modulation of systemic and mucosal immune responses to inhaled ragweed antigen in experimentally induced infection with respiratory syncytial virus implication in virally induced allergy. Int Arch Allergy Appl Immunol 86 (1):112-116.
33. Mastronarde JG, He B, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. 1996. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J Infect Dis 174 (2):262-267.
34. Matsuda K, Tsutsumi H, Okamoto Y, Chiba C. 1995. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immunol 2 (3):322-324.
35. McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM. 1978. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 138 (1):24-32.
36. McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL. 2004. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 23 (1):106-112.
37. Meusel TR, Imani F. 2003. Viral induction of inflammatory cytokines in human epithelial cells follows a p38 mitogen-activated protein kinase-dependent but NF-kappaB-independent pathway. J Immunol 171 (7):3768-3774.
38. Meusel TR, Kehoe KE, Imani F. 2002. Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J Immunol 168 (12):6429-6435.
39. Midulla F, Villani A, Panuska JR, Dab I, Kolls JK, Merolla R, Ronchetti R. 1993. Respiratory syncytial virus lung infection in infants: immunoregulatory role of infected alveolar macrophages. J Infect Dis 168 (6):1515-1519.
40. Miller AL, Bowlin TL, Lukacs NW. 2004. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J Infect Dis 189 (8):1419-1430.
41. Monick M, Staber J, Thomas K, Hunninghake G. 2001. Respiratory syncytial virus infection results in activation of multiple protein kinase C isoforms leading to activation of mitogen-activated protein kinase. J Immunol 166 (4):2681-2687.
42. Moore ML, Peebles RS, Jr. 2006. Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther 112 (2):405-424.
43. Neuzil KM, Tang Y W, Graham BS. 1996. Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo. Am J Med Sci 311 (5):201-204.
44. Noah TL, Becker S. 1993. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265 (5 Pt 1): L472-L478.
45. Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo R P. 1998. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 72 (6):4756-4764.
46. Pazdrak K, Olszewska-Pazdrak B, Liu T, Takizawa R, Brasier AR, Garofalo RP, Casola A. 2002. MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 283 (2):L364-L372.
47. Rager KJ, Langland JO, Jacobs BL, Proud D, Marsh DG, Imani F. 1998. Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J Virol 72 (2):1171-1176.
48. Rutigliano JA, Graham BS. 2004. Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 173 (5):3408-3417.
49. Sambrook JG, Beck S. 2007. Evolutionary vignettes of natural killer cell receptors. Curr Opin Immunol 19 (5):553-560.
50. Samuel CE. 1979. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci USA 76 (2):600-604.
51. Scheuner D, Gromeier M, Davies MV, Dorner AJ, Song B, Patel RV, Wimmer EJ, McLendon RE, Kaufman RJ. 2003. The doublestranded RNA-activated protein kinase mediates viral-induced encephalitis. Virology 317 (2):263-274.
52. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sanchez PJ, Ramilo O. 1999. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 18 (2):115-122.
53. Stapleton CM, Jaradat M, Dixon D, Kang HS, Kim SC, Liao G, Carey MA, Cristiano J, Moorman MP, Jetten AM. 2005. Enhanced susceptibility of staggerer (RORalphasg/sg) mice to lipopolysaccharide-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 289 (1):L144-L152.
54. Stojdl DF, Abraham N, Knowles S, Marius R, Brasey A, Lichty BD, Brown EG, Sonenberg N, Bell JC. 2000. The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74 (20):9580-9585.
55. Tripp RA. 2004. Pathogenesis of respiratory syncytial virus infection. Viral Immunol 17 (2):165-181.
56. Tripp RA, Jones L, Anderson LJ. 2000. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol 74 (13):6227-6229.
57. Welliver RC, Duffy L. 1993. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol 15 (1):19-27.
58. Welliver RC, Garofalo RP, Ogra PL. 2002. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection. Pediatr Infect Dis J 21 (5):457-461.
59. Welliver RC, Wong DT, Sun M, Middleton E, Jr., Vaughan RS, Ogra PL. 1981. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 305 (15):841-846.
60. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, Kumar A, Williams BR, Aguet M, Weissmann C. 1995. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14 (24):6095-6106.
61. Zamanian-Daryoush M, Mogensen TH, DiDonato JA, Williams BR. 2000. NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol Cell Biol 20 (4):1278-1290.
62. Zhang Y, Luxon BA, Casola A, Garofalo R P, Jamaluddin M, Brasier AR. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 75 (19):9044-9058.
63. Zhao MQ, Stoler MH, Liu AN, Wei B, Soguero C, Hahn YS, Enelow RI. 2000. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8 (+) T cell recognition. J Clin Invest 106 (6):R49-R58.
64. Zhou HR, Lau AS, Pestka JJ. 2003. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol Sci 74 (2):335-344.